跳至主要内容
临床试验/NCT05812339
NCT05812339Enrolling By Invitation不适用

Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls

University of Calgary2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
200
试验地点
2
主要终点
Gastric electrical signal frequency

研究概览

简要总结

This is an analytical validation observational cohort study is designed to provide evidence of: safety and reliability of Body Surface Gastric Mapping using the Gastric Alimetry System (GAS), normal reference values, and correlation of metrics with patient symptoms among healthy adults and patients diagnosed with upper abdominal motility disorders.

GAS is intended to record, store, view and process gastric myoelectrical activity. This is a proprietary system consisting of multiple electrodes arranged on an array that is placed precisely over the stomach, a reader to collect the electrode measurements and a smart tablet application to track patient reported symptoms. Participants meeting inclusion and exclusion criteria will continue fasting for 30 minutes after the Gastric Alimetry System has been applied and begun measuring, eat a standard study meal within 10 minutes and remain quietly seated, reclining, for 4 hours as the GAS continues to collect data. The array is removed and the abdomen is examined for evidence of skin effects.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Population:
  • Adults aged 18 years and over
  • Able to understand the risks/benefits of the study
  • Able to give written informed consent
  • No active gastrointestinal symptoms or pathology
  • Resides in the Calgary, Alberta area
  • Patient Population:
  • Adults aged 18 years and over
  • BMI > 35
  • Able to understand the risks/benefits of the study
  • Able to give written informed consent
  • Patients meeting Rome IV Criteria for functional dyspepsia, or a nausea and vomiting disorder
  • Patients with gastroparesis defined on a standardized gastric scintigraphy study
  • Resides in the Calgary, Alberta area

排除标准

  • Healthy Population:
  • Under 18 years of age
  • BMI > 35
  • Taking medications known to affect GI motility or the mid-gut axis (eg antidepressants, anti-anxiety medication, prokinetics, opiates)
  • Metabolic, neurogenic, or endocrine disorders known to cause gastrointestinal dysmotility (eg. Multiple Sclerosis, Parkinson's disease, hypothyroidism)
  • Known current GI infection (includes H. pylori when being actively treated)
  • Known current inflammatory bowel disease
  • Known current GI malignancy
  • Known GI functional or motility disorders
  • Previous gastroduodenal surgery
  • GI functional or motility disorders
  • Pregnant women
  • Open abdominal wounds or abdominal skin not intact (eg rash, abrasions, weeping tissue)
  • Fragile skin evidence by high susceptibility to skin tears or skin that bruises and breaks easily
  • Allergy to adhesives
  • History of allergy or intolerance to ingredients in the meal (nutrient drink, Ensure or similar and Clif bar or similar)
  • No vulnerable groups such as; prisoners, individuals with known cognitive impairment, or institutionalised individuals be involved
  • Regular cannabis use
  • Diagnosed with, or suspected to have life-threatening conditions that could result in immediate danger
  • Patient Population:
  • Under 18 years of age
  • BMI > 35
  • Metabolic, neurogenic, or endocrine disorders known to cause gastrointestinal dysmotility (eg. Multiple Sclerosis, Parkinson's disease, hypothyroidism)
  • Known current GI infection (includes H. pylori when being actively treated)
  • Known current inflammatory bowel disease
  • Known current GI malignancy
  • Previous gastroduodenal surgery
  • Open abdominal wounds or abdominal skin not intact (eg rash, abrasions, weeping tissue)
  • Fragile skin evidence by high susceptibility to skin tears or skin that bruises and breaks easily
  • Allergy to adhesives
  • Pregnant women
  • History of allergy or intolerance to ingredients in the meal (nutrient drink, Ensure or similar and Clif bar or similar)
  • No vulnerable groups such as; prisoners, individuals with known cognitive impairment, or institutionalised individuals be involved
  • Regular cannabis use except in the case of CHS
  • Diagnosed with, or suspected to have life-threatening conditions that could result in immediate danger
  • Inability to remain in a relaxed reclined position for the test duration

研究组 & 干预措施

Motility Disorder Patients

Adults with history of confirmed motility disorder.

干预措施: Gastric Alimetry System (Device)

Healthy Controls

Adults meeting all inclusion and exclusion criteria with no symptoms or history of motility disorder.

干预措施: Gastric Alimetry System (Device)

结局指标

主要结局

Gastric electrical signal frequency

时间窗: Post meal at 4 hours

Successful detection of gastric electrical signal in the 2-5 cycle-per-minute (cpm) spectrum as defined by reference ranges at Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal amplitude

时间窗: Post meal at 4 hours

Estimation of the power of the gastric electrical signal in the above frequency spectrum (μV) at a Reliability of 90% and Confidence Interval (CI) of 95%

Safety - abdominal skin effects

时间窗: 7 days post study visit

Incidence of skin irritation from the electrodes / adhesive, discomfort associated with device wear or removal

Upper Gastric Symptoms - nausea, bloating, upper gut pain, heartburn, stomach burn, excessively full

时间窗: Post meal at 4 hours

Self reported assessment of symptoms on a scale of 0-10 with 10 being most severe imaginable

Gastric electrical signal frequency

时间窗: Pre-meal

Successful detection of gastric electrical signal in the 2-5 cycle-per-minute (cpm) spectrum as defined by reference ranges at Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal frequency

时间窗: Post meal at 1 hour

Successful detection of gastric electrical signal in the 2-5 cycle-per-minute (cpm) spectrum as defined by reference ranges at Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal frequency

时间窗: Post meal at 2 hours

Successful detection of gastric electrical signal in the 2-5 cycle-per-minute (cpm) spectrum as defined by reference ranges at Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal frequency

时间窗: Post meal at 3 hours

Successful detection of gastric electrical signal in the 2-5 cycle-per-minute (cpm) spectrum as defined by reference ranges at Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal amplitude

时间窗: Pre-meal

Estimation of the power of the gastric electrical signal in the above frequency spectrum (μV) at a Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal amplitude

时间窗: Post meal at 1 hour

Estimation of the power of the gastric electrical signal in the above frequency spectrum (μV) at a Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal amplitude

时间窗: Post meal at 2 hours

Estimation of the power of the gastric electrical signal in the above frequency spectrum (μV) at a Reliability of 90% and Confidence Interval (CI) of 95%

Gastric electrical signal amplitude

时间窗: Post meal at 3 hours

Estimation of the power of the gastric electrical signal in the above frequency spectrum (μV) at a Reliability of 90% and Confidence Interval (CI) of 95%

Safety - abdominal skin effects

时间窗: After removal of Gastric Alimetry array at approximately 4.2 hours post meal

Incidence of skin irritation from the electrodes / adhesive, discomfort associated with device wear or removal

Safety - abdominal skin effects

时间窗: 24 hours post study visit

Incidence of skin irritation from the electrodes / adhesive, discomfort associated with device wear or removal

Upper Gastric Symptoms - nausea, bloating, upper gut pain, heartburn, stomach burn, excessively full

时间窗: Pre-meal

Self reported assessment of symptoms on a scale of 0-10 with 10 being most severe imaginable

Upper Gastric Symptoms - nausea, bloating, upper gut pain, heartburn, stomach burn, excessively full

时间窗: Post meal at 1 hour

Self reported assessment of symptoms on a scale of 0-10 with 10 being most severe imaginable

Upper Gastric Symptoms - nausea, bloating, upper gut pain, heartburn, stomach burn, excessively full

时间窗: Post meal at 2 hours

Self reported assessment of symptoms on a scale of 0-10 with 10 being most severe imaginable

Upper Gastric Symptoms - nausea, bloating, upper gut pain, heartburn, stomach burn, excessively full

时间窗: Post meal at 3 hours

Self reported assessment of symptoms on a scale of 0-10 with 10 being most severe imaginable

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验